tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Wittes, 70 are a BUY (83.33%), 14 are a HOLD (16.67%).
Analyst Jason Wittes, currently employed carries an average stock price target met ratio of 47.11% that have a potential upside of 27.33% achieved within 117 days. Previously, Jason Wittes worked at NORTHLAND CAPITAL MARKETS, AEGIS, BREAN.
Jason Wittes’s has documented 158 price targets and ratings displayed on 18 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on GMED, Globus Medical at 17-Dec-2024.
Analyst best performing recommendations are on LMAT (LEMAITRE VASCULAR).
The best stock recommendation documented was for LMAT (LEMAITRE VASCULAR) at 7/29/2015. The price target of $13 was fulfilled within 2 days with a profit of $1.32 (11.3%) receiving and performance score of 56.51.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$9
$7.15 (386.49%)
10 months 8 days ago
(13-Feb-2024)
0/3 (0%)
$6.25 (227.27%)
Buy
$7
$5.15 (278.38%)
$9.5
2 years 5 months 27 days ago
(24-Jun-2022)
0/2 (0%)
$4.94 (239.81%)
Buy
$10
$8.15 (440.54%)
$10
3 years 1 months 25 days ago
(26-Oct-2021)
0/5 (0%)
$5.7 (132.56%)
Which stock is Jason Wittes is most bullish on?
Which stock is Jason Wittes is most reserved on?
What Year was the first public recommendation made by Jason Wittes?
